Jonsson MKB - Search Results

1

Inhibiting cardiac myeloperoxidase alleviates the relaxation defect in hypertrophic cardiomyocytes.

Ramachandra CJA, Kp MMJ, Chua J, Hernandez-Resendiz S, Liehn EA, Knöll R, Gan LM, Michaëlsson E, Jonsson MKB, Ryden-Markinhuhta K, Bhat RV, Fritsche-Danielson R, Lin YH, Sadayappan S, Tang HC, Wong P, Shim W, Hausenloy DJ. Ramachandra CJA, et al. Among authors: jonsson mkb. Cardiovasc Res. 2022 Jan 29;118(2):517-530. doi: 10.1093/cvr/cvab077. Cardiovasc Res. 2022. PMID: 33705529 Free PMC article.

2

The influence of hERG1a and hERG1b isoforms on drug safety screening in iPSC-CMs.

Goversen B, Jonsson MK, van den Heuvel NH, Rijken R, Vos MA, van Veen TA, de Boer TP. Goversen B, et al. Prog Biophys Mol Biol. 2019 Dec;149:86-98. doi: 10.1016/j.pbiomolbio.2019.02.003. Epub 2019 Feb 27. Prog Biophys Mol Biol. 2019. PMID: 30826123

3

Personalized medicine and the role of induced pluripotent stem cells.

van der Heyden MA, Jonsson MK. van der Heyden MA, et al. Cardiovasc Res. 2012 Sep 1;95(4):395-6. doi: 10.1093/cvr/cvs242. Epub 2012 Jul 20. Cardiovasc Res. 2012. PMID: 22822102 No abstract available.

4

Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes.

Jonsson MK, Wang QD, Becker B. Jonsson MK, et al. Assay Drug Dev Technol. 2011 Dec;9(6):589-99. doi: 10.1089/adt.2011.0396. Epub 2011 Nov 15. Assay Drug Dev Technol. 2011. PMID: 22085047 Free PMC article.

5

Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.

van den Heuvel NH, van Veen TA, Lim B, Jonsson MK. van den Heuvel NH, et al. J Mol Cell Cardiol. 2014 Feb;67:12-25. doi: 10.1016/j.yjmcc.2013.12.011. Epub 2013 Dec 23. J Mol Cell Cardiol. 2014. PMID: 24370890 Review.

6

Epigenetics: DNA demethylation promotes skeletal myotube maturation.

Hupkes M, Jonsson MK, Scheenen WJ, van Rotterdam W, Sotoca AM, van Someren EP, van der Heyden MA, van Veen TA, van Ravestein-van Os RI, Bauerschmidt S, Piek E, Ypey DL, van Zoelen EJ, Dechering KJ. Hupkes M, et al. FASEB J. 2011 Nov;25(11):3861-72. doi: 10.1096/fj.11-186122. Epub 2011 Jul 27. FASEB J. 2011. PMID: 21795504

7

A Transcriptomic and Epigenomic Comparison of Fetal and Adult Human Cardiac Fibroblasts Reveals Novel Key Transcription Factors in Adult Cardiac Fibroblasts.

Jonsson MKB, Hartman RJG, Ackers-Johnson M, Tan WLW, Lim B, van Veen TAB, Foo RS. Jonsson MKB, et al. JACC Basic Transl Sci. 2016 Nov 30;1(7):590-602. doi: 10.1016/j.jacbts.2016.07.007. eCollection 2016 Dec. JACC Basic Transl Sci. 2016. PMID: 30167544 Free PMC article. Review.

8

Towards Creating the Perfect In Vitro Cell Model.

Jonsson MK, van Veen TA, Synnergren J, Becker B. Jonsson MK, et al. Stem Cells Int. 2016;2016:3459730. doi: 10.1155/2016/3459730. Epub 2016 Feb 3. Stem Cells Int. 2016. PMID: 26955392 Free PMC article. No abstract available.

9

Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes.

Jonsson MK, Duker G, Tropp C, Andersson B, Sartipy P, Vos MA, van Veen TA. Jonsson MK, et al. Stem Cell Res. 2010 May;4(3):189-200. doi: 10.1016/j.scr.2010.02.001. Epub 2010 Feb 17. Stem Cell Res. 2010. PMID: 20303332 Free article.

10

Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG.

Jonsson MK, Vos MA, Mirams GR, Duker G, Sartipy P, de Boer TP, van Veen TA. Jonsson MK, et al. J Mol Cell Cardiol. 2012 May;52(5):998-1008. doi: 10.1016/j.yjmcc.2012.02.002. Epub 2012 Feb 14. J Mol Cell Cardiol. 2012. PMID: 22353256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page